Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study is a paper indexed in PICO Portal from OpenAlex.
How many citations does Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study have?
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study has 230 citations in the OpenAlex counts PICO Portal stores.
When was Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study published?
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study has 2008 year in the PICO Portal index.
What is the open-access status of Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study?
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study has green oa status in the PICO Portal index.
What is the DOI of Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study?
The DOI for Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study is on the source record.
What is the PMID of Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study?
The PMID for Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study is on the source record.
What is the OpenAlex record for Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study?
The OpenAlex for Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study is on the source record.